Anti-EGFR-MDNA109FA

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-EGFR-MDNA109FA
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunologic cytotoxicityInterleukin-2 receptor beta chain agonistsCytotoxic T lymphocytes stimulants
TargetsInterleukin-2 receptor beta chainCluster of differentiation 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMedicenna Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A